Suppression of 18F-FDG myocardial uptake using a fat-allowed, carbohydrate-restricted diet

Journal of Nuclear Medicine Technology

Volumn 39, Issue 3, 2011, Pages 185-189

  Balink, Hans ^a   Hut, Evelien ^b   Pol, Thomas ^b   Flokstra, Freerk Jan ^b   Roef, Mark ^c  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b HANZE UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

18F FDG; Carbohydrate restricted diet; Myocardial uptake

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HEART MUSCLE; HUMAN; LIPID DIET; LIVER; LOW CARBOHYDRATE DIET; MAJOR CLINICAL STUDY; FAT INTAKE; FEMALE; HEART; MALE; METABOLISM; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING;

DIET, CARBOHYDRATE-RESTRICTED; DIETARY FATS; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; MALE; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

EID: 82855177813     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnmt.110.076489     Document Type: Article

References (15)

1. de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging. 2005;32:98-101.
2. 18F-FDG PET/CT. J Nucl Med. 2007;48: 1662-1669.
3. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61-77.
4. Ojha B, Bartley SC, Gundlapalli S, Mountz J. Effect of dietary intake before F-18 FDG positron emission tomographic scanning on the evaluation of a solitary pulmonary nodule. Clin Nucl Med. 2001;26:908-909.
5. Lum D, Wandell S, Ko J, Coel M. 1. Positron emission tomography of thoracic malignancies. reduction of myocardial fluorodeoxyglucose uptake artifacts with a carbohydrate restricted diet [abstract]. Clin Positron Imaging. 2000;3:155.
6. Antoch G, Kuehl H, Kanja J, et al. Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation. Radiology. 2004;230:879-885.
7. Balink H, Collins J, Bruyn G, Gemmel F. F18-FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med. 2009;34:862-868.
8. Wykrzykowska J, Lehman S, Williams G, et al. Imaging of inflamed and vulnerable plaque in coronary arteries with F18-FDG PET/CT in patients with sup-pression of myocardial uptake using a low-carbohydate, high-fat preparation. J Nucl Med. 2009;50:563-568.
9. Lam MGE, Dekkers EJM, van Dongen AJ, et al. Does caffeine influence myocardial FDG uptake? [abstract] Eur J Nucl Med Mol Imaging. 2004;31(suppl): S205.
10. de Swart J, Snoek-Klaver I, Valkema R, et al. The influence of caffeine on the uptake of F18-FDG in the myocardium [abstract]. Eur J Nucl Med Mol Imaging. 2004;31(suppl):S484.
11. Williams G, Kolodny GM. Suppression of myocardial F18-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR. 2008;190:W151-W156.
12. Frayn KN. The glucose-fatty acid cycle; a physiological perspective. Biochem Soc Trans. 2003;31:1115-1119.
13. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty-acid induced inhibition of glucose uptake. J Clin Invest. 1994;93:2438-2446.
14. Armoni M, Harel C, Bar-Yoseph F, Milo S, Karnieli E. Free fatty acids repress the GLUT4 gene expression in cardiac muscle via novel response elements. J Biol Chem. 2005;280:34786-34795.
15. Fine EJ, Miao W, Koba W, Volek JS, Blaufox MD. Chronic effects of dietary carbohydrate variation on (18F)-2-fluoro-2-deoxyglucose uptake in rodent heart. Nucl Med Commun. 2009;30:675-680.